Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
06/1991
06/23/1991CA2066442A1 Method of preparation of hirudin
06/22/1991CA2032607A1 Separation material for blood coagulation factor' preparation and use thereof
06/21/1991CA2018377A1 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques
06/20/1991WO1991009126A1 Production of human basic fgf mutein
06/20/1991CA2070989A1 Production of human basic fgf mutein
06/19/1991EP0433225A1 Process for the production of biologically active protein (e.g. TGF)
06/19/1991EP0433088A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/19/1991EP0432965A1 Malaria vaccine
06/19/1991EP0432629A1 Method for binding immunoglobulin G to protein A
06/19/1991EP0432419A1 Method for solubilization and naturation of somatotropins utilizing low urea concentration
06/19/1991EP0432218A1 Method for detecting cellular pathology.
06/19/1991EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use
06/19/1991EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications
06/19/1991CN1052331A Novel antigens and methods therefor
06/19/1991CA2032389A1 Reagents
06/18/1991US5025388 Comparative molecular field analysis (CoMFA)
06/18/1991US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
06/18/1991CA1285099C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
06/16/1991CA2032430A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
06/16/1991CA2032359A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/15/1991CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/14/1991CA2071858A1 Hiv-1 env fragment fusion protein
06/13/1991WO1991008478A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
06/13/1991WO1991008225A1 Hexapeptides with sulphate ester groups
06/13/1991WO1991008220A1 A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines
06/13/1991WO1991008190A1 Amino acid protecting groups
06/12/1991EP0432134A1 Hybridoma cell lines and monoclonal antibodies
06/12/1991EP0432022A1 Medium for reaction and dissolution of peptides and process of peptide synthesis by making use of said medium
06/12/1991EP0431882A2 Pre-activated proteins for labelling oligonucleotide probes
06/12/1991EP0431350A1 New polypeptide compound and a process for preparation thereof
06/12/1991EP0431327A1 Synthetic vaccine for the specific induction of cytotoxic T-lymphocytes
06/12/1991EP0431189A1 Method of assisting material design and apparatus therefor
06/12/1991EP0431059A1 A method for carrying out organic chemical reactions and apparatus for carrying out that method.
06/12/1991EP0431042A1 A method of preparing an active human neutrophil chemotactic factor polypeptide.
06/12/1991CA2031763A1 Process for purification of a 69000 dalton antigentic protein from bordetella pertussis
06/11/1991US5023802 Method for processing information on chemical reactions
06/11/1991US5023323 Method of somatotropin naturation
06/11/1991CA1284850C Carboxyalkyl peptide derivatives
06/09/1991CA2031684A1 Pharmaceuticals
06/09/1991CA2031468A1 Malaria vaccine
06/08/1991WO1991009053A1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
06/08/1991CA2069449A1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
06/08/1991CA2031644A1 Peptide antiviral agents
06/06/1991WO1991007978A1 Synthetic calcitonin peptides
06/06/1991CA2069943A1 Synthetic calcitonin peptides
06/06/1991CA2031369A1 Method for solubilization and naturation of somatotropins utilizing low urea concentration
06/05/1991EP0430930A1 Factor IX protein
06/05/1991EP0430637A1 Fibrinolytic protein and production method thereof
06/05/1991EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component
06/05/1991EP0429611A1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins
06/05/1991EP0429537A1 Atrial natriuretic peptide clearance inhibitors
06/05/1991EP0429502A1 O-glycosylated igf-1
06/05/1991EP0429470A1 Antibody recognition of fragments from cytomegalovirus
06/05/1991CN1051937A Stem cell factor
06/05/1991CN1051936A Drythropoietin isoforms
06/05/1991CN1051914A Peptides
06/04/1991US5021567 8-hydroxyquinoline chelating agents
06/04/1991US5021554 Process for protein particle size reduction using a fluid-energy mill
06/04/1991US5021551 Method of enhancing peptide immunogenicity
06/04/1991US5021550 Method for preventing deletion sequences in solid phase synthesis
05/1991
05/30/1991WO1991008285A1 Production of recombinant human interleukin-1 inhibitor
05/30/1991WO1991007439A1 Control of secretion of milk
05/30/1991WO1991007429A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety
05/30/1991WO1991007428A1 A protein purification method
05/30/1991WO1991007427A1 Carrier for column chromatography, process for separating and purifying water-soluble polymeric substance using said carrier, novel pectic acid-cellulose gel and process for preparing the same, and adsorbent for affinity chromatography
05/30/1991WO1991007190A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
05/30/1991CA2068533A1 Control of secretion of milk
05/30/1991CA2030947A1 Process for the production of unfused protein in e. coli
05/29/1991EP0428849A2 Retroviral protease inhibitors
05/29/1991EP0428758A1 Albumin preparation and method of producing the same
05/29/1991CN1051757A Polypeptide compound and process for preparation thereof
05/29/1991CN1051732A Method for isolating biologically active compounds
05/28/1991US5019500 IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof
05/28/1991US5019348 Automated chemical conversion unit in a peptide/protein sequenator
05/28/1991CA2030927A1 Fibrinolytic protein and production method thereof
05/28/1991CA2030720A1 Hexapeptides with sulphate ester groups
05/28/1991CA1284550C Retro-inverso analogs of the bradykinin potentiating peptide bpp*in5a*xx
05/28/1991CA1284507C Melphalan derivatives
05/23/1991CA2069402A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
05/23/1991CA2030212A1 Peptides
05/22/1991EP0428486A1 Polymyxin conjugates
05/22/1991EP0428367A1 Isolation and structural elucidation of the cytostatic linear depsipetide dolastatin 14
05/22/1991EP0428267A2 Erythropoietin isoforms
05/22/1991EP0428188A2 Novel immunoconjugates and methods for their use in tumor therapy
05/22/1991EP0427745A1 Solid phase assembly and reconstruction of biopolymers
05/22/1991EP0203095B1 Process of preparing polyamide supports capable of reaction with antibodies and enzymes and supports produced thereby.
05/21/1991US5017292 Permselective
05/17/1991WO1991007426A1 Bioavailable iron-albumin compounds, a process for the preparation thereof and pharmaceutical compositions containing them
05/17/1991CA2068655A1 Bioavailable iron-albumin compounds, a process for the preparation thereof and pharmaceutical compositions containing them
05/16/1991WO1991006851A1 Flow-rate controlled surface charge coating for capillary electrophoresis
05/16/1991WO1991006571A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
05/16/1991WO1991006566A1 Novel compounds
05/16/1991WO1991006560A1 Cross-linked tumour necrosis factors
05/16/1991WO1991006558A1 Process for peptide synthesis and vehicles therefor
05/16/1991WO1991006319A1 Methods and compositions for promoting immunopotentiation
05/16/1991CA2071478A1 Methods and compositions for promoting immunopotentiation
05/16/1991CA2029997A1 Polymyxin conjugates
05/15/1991EP0427462A1 Process
05/15/1991EP0427189A1 Modified forms of human erythropoietin and DNA sequences encoding genes which can express them
05/15/1991EP0427162A1 Novel insulin derivatives, their preparation and use, and a pharmaceutical composition thereof
1 ... 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 ... 518